Controlled drug delivery high molecular weight polyanhydrides
First Claim
1. A bioerodible controlled drug release device comprising a homogeneous polymeric matrix of:
- (a) an effective amount of at least one biologically active substance, and;
(b) a high molecular weight hydrophobic polyanhydride copolymer having a weight average molecular weight greater than 20,000 and an intrinsic viscosity greater than 0.3 dl/in chloroform at 23°
C., said polyanhydride produced from at least one dicarboxylic acid selected from the group consisting of;
aliphatic dicarboxylic acids having the formula;
space="preserve" listing-type="equation">HOOC--H.sub.2 --C--R--CH.sub.2 --COOH;
aromatic dicarboxylic acids having the formula;
##STR1## aromatic dicarboxylic acids having the formula;
##STR2## aliphatic-aromatic dicarboxylic acids having the formula;
##STR3## aromatic and aliphatic heterocyclic dicarboxylic acids having the formula;
##STR4## wherein X is selected from the group consisting of oxygen, nitrogen, and sulfur, andn is an integer between 1 and 3; and
aromatic and aliphatic heterocyclic dicarboxylic acids of the above formula in combination with at least one dicarboxylic acid selected from the group consisting of aliphatic dicarboxylic acids, aromatic-aliphatic dicarboxylic acids, and aromatic dicarboxylic acids having more than one phenyl group;
wherein the R groups are divalent organic radical groups.
2 Assignments
0 Petitions
Accused Products
Abstract
A bioerodible controlled drug release device is produced as a homogeneous polymeric matrix from a high molecular weight polyanhydride and a suitable biologically active substance. The high molecular weight polyanhydride is defined by a molecular weight greater than 20,000 and an intrinsic viscosity greater than 0.3 dl/g. The controlled drug release device is preferrably formed by solvent casting with the biologically active substance and exhibits zero order release, improved correlation between the rate of release and polymer degradation, and an induction period between introduction to the eroding environment and the initial release of the biologically active substance. The controlled drug release devices are stable for extended periods of time, flexible and durable and not subject to fracture and disintegration.
175 Citations
18 Claims
-
1. A bioerodible controlled drug release device comprising a homogeneous polymeric matrix of:
-
(a) an effective amount of at least one biologically active substance, and; (b) a high molecular weight hydrophobic polyanhydride copolymer having a weight average molecular weight greater than 20,000 and an intrinsic viscosity greater than 0.3 dl/in chloroform at 23°
C., said polyanhydride produced from at least one dicarboxylic acid selected from the group consisting of;aliphatic dicarboxylic acids having the formula;
space="preserve" listing-type="equation">HOOC--H.sub.2 --C--R--CH.sub.2 --COOH;aromatic dicarboxylic acids having the formula;
##STR1## aromatic dicarboxylic acids having the formula;
##STR2## aliphatic-aromatic dicarboxylic acids having the formula;
##STR3## aromatic and aliphatic heterocyclic dicarboxylic acids having the formula;
##STR4## wherein X is selected from the group consisting of oxygen, nitrogen, and sulfur, andn is an integer between 1 and 3; and aromatic and aliphatic heterocyclic dicarboxylic acids of the above formula in combination with at least one dicarboxylic acid selected from the group consisting of aliphatic dicarboxylic acids, aromatic-aliphatic dicarboxylic acids, and aromatic dicarboxylic acids having more than one phenyl group; wherein the R groups are divalent organic radical groups. - View Dependent Claims (2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14)
-
-
15. A bioerodible controlled release device adapted for dispensing at least one biologically active substance at a controlled rate comprising a homogeneous polymeric matrix of:
-
(a) an effective amount of at least one biologically active substance; and (b) a hydrophobic polyanhydride copolymer having a weight average molecular weight greater than 20,000 and an intrinsic viscosity greater than 0.3 dl/g in chloroform at 23°
C., said polyanhydride produced from at least one dicarboxylic acid selected from the group consisting of;aliphatic dicarboxylic acids having the formula;
space="preserve" listing-type="equation">HOC--H.sub.2 --C--R--CH.sub.2 --COOH;aromatic dicarboxylic acids having the formula;
##STR5## aromatic dicarboxylic acids having the formula;
##STR6## aliphatic-aromatic dicarboxylic acids having the formula;
##STR7## aromatic and aliphatic heterocyclic dicarboxylic acids having the formula;
##STR8## nitrogen and sulfur, and whereinX is selected from the group consisting of oxygen, n is an integer between 1 and 3; and aromatic and aliphatic heterocyclic dicarboxylic acids of the above formula in combination with at least one dicarboxylic acid selected from the group consisting of aliphatic dicarboxylic acids, aromatic-aliphatic dicarboxylic acids, and aromatic dicarboxylic acids having more than one phenyl group; wherein the R groups are divalent organic radical groups, wherein said polyanhydride includes at least 5% aromatic repeating units. - View Dependent Claims (16)
-
-
17. A bioerodible composition comprising at least one biologically active substance and a high molecular weight polyanhydride having a molecular weight greater than 20,000, an intrinsic viscosity greater than 0.3 dl/g in chloroform at 23°
- C., said polyanhydride having at least 20% aromatic repeating units.
- View Dependent Claims (18)
Specification